Products
- Anti-Obesity Compound Library
- GPCR/G Protein-Targeted Compounds
- Immunology/Inflammation-Targeted Compounds
- JAK/STAT-Targeted Compounds
- MAPK-Targeted Compounds
- Membrane Transporter/Ion Channel-Targeted Compounds
- Metabolism-Targeted Compounds
- NF-κB-Targeted Compounds
- Microbiology/Virology-Targeted Compounds
- Neuronal Signaling-Targeted Compounds
- PI3K/Akt/mTOR-Targeted Compounds
- Oxidation-reduction-Targeted Compounds
- Proteases/Proteasome-Targeted Compounds
- Stem Cells/Wnt-Targeted Compounds
- Tyrosine Kinase/Adaptors-Targeted Compounds
- Ubiquitin-Targeted Compounds
Online Inquiry
Perifosine
Cat. No.:
OB0225LY-0382
Appearance:
Solid
Purity:
≥99%
Identity:
Confirmed by NMR and LC-MS.
Size:
Add to basket
Product Overview
Description:
Perifosine is an orally available biological agent that belongs to a class of phospholipid complexes with the ability to modulate cell signaling pathways.
Synonym:
NSC 639966; D21266; KRX-0401; 157716-52-4; 1,1-Dimethylpiperidin-1-ium-4-yl octadecyl phosphate; 1,1-Dimethylpiperidinium-4-yl octadecyl phosphate; 4-Hydroxy-1,1-dimethylpiperidinium hydroxide, octadecyl hydrogen phosphate, inner salt
CAS No.:
157716-52-4
Compound CID:
148177
Formula:
C25H52NO4P
Formula Weight:
461.66
Specification
Stability:
3 years in powder form.
Storage:
Storage at -20°C.
Applications:
Perifosine can be used in signal transduction studies of tumor cells to explore its effect on cancer cell proliferation or play an important role in drug combination studies.
Library Information
Targets:
Akt
Pathways:
Apoptosis; PI3K/Akt/mTOR signaling; Autophagy; Cytoskeletal signaling
Plate Number:
AOCL-5
Plate Location:
h7
Empty Location:
a1-h1; a12-h12
Container:
96-well plate
Formulation:
10 mM Water
Water Max Solubility:
10 mM
Solubility:
Insoluble in DSMO.
ALogP:
4.607
HBA_Count:
2
HBD_Count:
0
Rotatable Bond:
20
